Roxane's morphine solution receives FDA approval

01/26/2010 | United Press International · Bloomberg Businessweek

The FDA approved Roxane Laboratories' morphine sulfate oral solution for opioid-tolerant patients with moderate to severe pain. The approval covers the doses of 100 milligrams per 5 milliliters and 20 milligrams per 1 milliliter.

View Full Article in:

United Press International · Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID